SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Michelle Fay Cortez
Health
COVID still kills 1 person every 4 minutes despite the global emergency being officially over
By
Michelle Fay Cortez
and
Bloomberg
Health
Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease
By
Michelle Fay Cortez
and
Bloomberg
Health
T cells fight off severe Omicron, says a new Dutch and South African study
By
Marthe Fourcade
,
Michelle Fay Cortez
, and others
Health
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
By
Michelle Fay Cortez
and
Bloomberg
Health
Moderna’s CEO believes new COVID vaccines are likely needed to protect against the Omicron variant
By
Michelle Fay Cortez
and
Bloomberg
International
A viral video of government workers killing a corgi is terrifying China’s pet owners
By
Jenni Marsh
,
Michelle Fay Cortez
, and others
Health
Those with previous COVID infections may be less likely to catch Delta than those vaccinated with Pfizer
By
Michelle Fay Cortez
and
Bloomberg
International
A silver lining for places low on vaccines: a delayed second dose may provide stronger immunity
By
Michelle Fay Cortez
and
Bloomberg
International
For ‘COVID Zero’ success stories, opening up is hard to do
By
Michelle Fay Cortez
,
Jinshan Hong
, and others
International
AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data
By
James Paton
,
Michelle Fay Cortez
, and others
Health
AstraZeneca’s U.S. COVID trial in doubt after agency says drugmaker may have submitted outdated data
By
Michelle Fay Cortez
,
Jason Gale
, and others
Health
A faster-spreading COVID variant puts a spotlight on the U.S. vaccine rollout
By
Michelle Fay Cortez
,
Anna Edney
, and others
International
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
By
Michelle Fay Cortez
,
Riley Griffin
, and others
Health
Study: COVID-19 antibodies don’t last very long, raising risk of lost immunity
By
Michelle Fay Cortez
,
Niclas Rolander
, and others
Health
As hospitalizations hit new records and states impose quarantines, businesses reconsider reopening
By
Margaret Newkirk
,
Jonathan Levin
, and others